Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/14667889
Conclusion of this study
Administration of low doses (25 mg) of DHEA positively modulates several endocrine parameters in early and late postmenopausal women, inducing the increase of the androgenic, estrogenic, and progestogenic milieu and reducing the climateric symptoms, similarly to estroprogestin replacement therapy. These data suggest that DHEA supplementation is a more effective replacement therapy than a simple "dietary supplement."
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study